Pressreleases

One does it all: Sartorius Stedim Biotech unveils a new generation of its successful laboratory bioreactor series BIOSTAT® B

Sartorius Stedim Biotech (SSB), a leading international pharma and biotech provider, is bringing a completely revamped generation of its successful bioreactor series out on the market: BIOSTAT® B. This autoclavable fermentor / bioreactor has been specially designed to cover the wide variety of requirements in biotechnological and biopharmaceutical research and development.

Energy Globe Award Sweden goes to EnviroChemie

In May 2012 EnviroChemie was awarded the Energy Globe Award Sweden for its sustainable wastewater treatment process with biogas recovery. Christoph Sturm, the Austrian Trade Attaché, presented the award on behalf of the Austrian Energy Globe Foundation.

Watson-Marlow Pumps Group launches PureWeld XL, a weldable peristaltic pump tube

Watson-Marlow Pumps Group has launched PureWeld XL, a weldable and ADCF (animal-derived contents free) tube for use in biopharmaceutical processes, including single-use applications. Designed for secure peristaltic pumping and improved performance, PureWeld XL can be securely welded, allowing complete connector-free fluid paths to be assembled in minutes.

Flexicon celebrates 25 years of success

Flexicon Liquid Filling Systems, part of the Watson-Marlow Pumps Group, is celebrating 25 years of success as a leading manufacturer and supplier of world-class aseptic liquid filling and capping systems.

‘Small and simple’: Watson-Marlow’s new 120 peristaltic pump

With development based on extensive feedback from customers, Watson-Marlow Pumps Group has launched its new 120 cased peristaltic pump range. The new 120 pumps are perfectly suited to single-use systems where no contamination can be accepted.

EnviroChemie wins order for wastewater deactivation and detoxification from major vaccine producer.

The wastewater from vaccine production at a world-leading pharmaceutical company will be safely deactivated and processed before being released into the sewer system.

Logistics in 2012; What’s next?

We have been faced with turbulent times over the last year or so and it shows no signs of slowing just yet. Companies are making cut backs left, right and centre – taking a good look at their expenditures and trying to shave off cost wherever possible. Some easy targets are contracts for services they use regularly, scrutinising the invoice for little extras that have been happily rolling over each month.

Pierrel Research confirms its strong and competitive expertise in the Respiratory Area

The FORTE Study: Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial has been recently published on 25 June 2012.

Memantine effects measured with the Relevant Outcome Scale for Alzheimer’s disease in an open-label, single-arm, multicenter clinical study

Pierrel Research is pleased to announce the recent publication in International Journal of Geriatric Psychiatry on the ROSA trial results.